Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …

Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19)
has posed a multitude of challenges to health care systems worldwide. In order to combat …

Thromboplasminflammation in coronavirus disease 2019 (COVID-19) coagulopathy consists
of angiotensin II (Ang II)-induced coagulopathy, activated factor XII (FXIIa)-and kallikrein …

Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …

Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …

Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …

SARS-CoV-2 causes a phenotype of pneumonia with diverse manifestation, which is termed
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …

There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …

An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …